A prospective follow-up post-authorization study assessing Eliglustat
Latest Information Update: 10 Aug 2022
At a glance
- Drugs Eliglustat (Primary)
- Indications Gaucher's disease type I
- Focus Adverse reactions; Therapeutic Use
- Acronyms Trazelga
- 17 Jun 2022 Preliminary results presented at the 27th Congress of the European Haematology Association
- 21 Jul 2020 New trial record
- 21 Jun 2020 Results presented at the 25th Congress of the European Haematology Association